Literature DB >> 29479848

The inflammation - cancer connection.

Alberto Mantovani1,2,3.   

Abstract

This Special Issue comprises ten reviews that highlight the connection between inflammation and cancer; from immune-cancer cell crosstalk to the current targets in cancer immunotherapy. We hope you find these reviews interesting and informative and we thank the authors for these excellent contributions.
© 2018 Federation of European Biochemical Societies.

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29479848      PMCID： PMC5935239          DOI： 10.1111/febs.14395

Source DB:  PubMed          Journal:  FEBS J        ISSN： 1742-464X            Impact factor:   5.542


  21 in total

Review 1.  Innate and acquired immune surveillance in the postdissemination phase of metastasis.

Authors:  Hugo Gonzalez; Isabella Robles; Zena Werb
Journal:  FEBS J       Date:  2017-11-24       Impact factor: 5.542

Review 2.  The roles of CSFs on the functional polarization of tumor-associated macrophages.

Authors:  Pascale Jeannin; Léa Paolini; Clement Adam; Yves Delneste
Journal:  FEBS J       Date:  2017-12-16       Impact factor: 5.542

Review 3.  Neutrophils, G-CSF and their contribution to breast cancer metastasis.

Authors:  Kellie A Mouchemore; Robin L Anderson; John A Hamilton
Journal:  FEBS J       Date:  2017-09-21       Impact factor: 5.542

Review 4.  Beyond the M-CSF receptor - novel therapeutic targets in tumor-associated macrophages.

Authors:  Stefano Bonelli; Xenia Geeraerts; Evangelia Bolli; Jiri Keirsse; Mate Kiss; Ana Rita Pombo Antunes; Helena Van Damme; Karen De Vlaminck; Kiavash Movahedi; Damya Laoui; Geert Raes; Jo A Van Ginderachter
Journal:  FEBS J       Date:  2017-09-06       Impact factor: 5.542

5.  PTX3 is an extrinsic oncosuppressor regulating complement-dependent inflammation in cancer.

Authors:  Eduardo Bonavita; Stefania Gentile; Marcello Rubino; Virginia Maina; Roberto Papait; Paolo Kunderfranco; Carolina Greco; Francesca Feruglio; Martina Molgora; Ilaria Laface; Silvia Tartari; Andrea Doni; Fabio Pasqualini; Elisa Barbati; Gianluca Basso; Maria Rosaria Galdiero; Manuela Nebuloni; Massimo Roncalli; Piergiuseppe Colombo; Luigi Laghi; John D Lambris; Sébastien Jaillon; Cecilia Garlanda; Alberto Mantovani
Journal:  Cell       Date:  2015-02-12       Impact factor: 41.582

Review 6.  Neutralizing tumor-promoting chronic inflammation: a magic bullet?

Authors:  Lisa M Coussens; Laurence Zitvogel; A Karolina Palucka
Journal:  Science       Date:  2013-01-18       Impact factor: 47.728

7.  Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial.

Authors:  Paul M Ridker; Jean G MacFadyen; Tom Thuren; Brendan M Everett; Peter Libby; Robert J Glynn
Journal:  Lancet       Date:  2017-08-27       Impact factor: 79.321

Review 8.  Metabolism and TAM functions-it takes two to tango.

Authors:  Massimiliano Mazzone; Alessio Menga; Alessandra Castegna
Journal:  FEBS J       Date:  2017-11-08       Impact factor: 5.542

Review 9.  Hallmarks of cancer: the next generation.

Authors:  Douglas Hanahan; Robert A Weinberg
Journal:  Cell       Date:  2011-03-04       Impact factor: 41.582

Review 10.  Tumour-associated macrophages as treatment targets in oncology.

Authors:  Alberto Mantovani; Federica Marchesi; Alberto Malesci; Luigi Laghi; Paola Allavena
Journal:  Nat Rev Clin Oncol       Date:  2017-01-24       Impact factor: 66.675
View more
  16 in total

1.  The emerging spectrum of early life exposure-related inflammation and epigenetic therapy.

Authors:  Qiwei Yang; Mohamed Ali; Abdeljabar El Andaloussi; Ayman Al-Hendy
Journal:  Cancer Stud Mol Med       Date:  2018-09-17

Review 2.  Contribution of RAGE axis activation to the association between metabolic syndrome and cancer.

Authors:  Ma Eugenia Garay-Sevilla; Armando Gomez-Ojeda; Ileana González; Claudia Luévano-Contreras; Armando Rojas
Journal:  Mol Cell Biochem       Date:  2021-01-04       Impact factor: 3.396

3.  Increased ATP2A1 Predicts Poor Prognosis in Patients With Colorectal Carcinoma.

Authors:  Guoshun Zhang; Hua Shang; Bin Liu; Guikai Wu; Diyang Wu; Liuqing Wang; Shengnan Li; Zhiyuan Wang; Suying Wang; Juxiang Yuan
Journal:  Front Genet       Date:  2022-06-16       Impact factor: 4.772

4.  The Combination of Plasma Fibrinogen Concentration and Neutrophil Lymphocyte Ratio (F-NLR) as a Prognostic Factor of Epithelial Ovarian Cancer.

Authors:  Jiani Yang; Jun Ma; Shanshan Cheng; Yu Wang
Journal:  Onco Targets Ther       Date:  2020-07-27       Impact factor: 4.147

5.  Clinical and prognostic significance of combined plasma fibrinogen concentrations and the monocyte-to-lymphocyte ratio in patients with ovarian cancer.

Authors:  Yuanyuan Cao; Xiuwen Ni; Yong Wang; Lejian Wang; Kai Yuan; Guofang Gan; Kunming Zhang; Zhidi Zhao; Xianming Fei
Journal:  Ann Transl Med       Date:  2019-06

6.  Camel Urine Promotes Sensitization to Doxorubicin by Inhibiting Epithelial-Mesenchymal Transition and Modulating NF-κB-Snail Signaling Pathway in Breast Cancer Cells.

Authors:  Mashael Saqer Al-Mutairi; Ibtehal Kamal Matar; Suad Alfadli; Awated Al-Mutairi
Journal:  Asian Pac J Cancer Prev       Date:  2021-12-01

7.  Morita-Baylis-Hillman Adduct 2-(3-Hydroxy-2-oxoindolin-3-yl)acrylonitrile (ISACN) Modulates Inflammatory Process In vitro and In vivo.

Authors:  Juliane Santos de França; José Marreiro de Sales-Neto; Deyse Cristina Madruga Carvalho; Éssia de Almeida Lima; Tayná Rodrigues Olegário; Rhuan Karlos Santos Mendes; Claudio Gabriel Lima-Junior; Mário Luiz Araújo de Almeida Vasconcellos; Sandra Rodrigues-Mascarenhas
Journal:  Inflammation       Date:  2020-11-24       Impact factor: 4.657

Review 8.  P53, GHRH, inflammation and cancer.

Authors:  Nektarios Barabutis; Andrew V Schally; Agnieszka Siejka
Journal:  EBioMedicine       Date:  2018-10-19       Impact factor: 8.143

9.  MicroRNA-139-5p regulates chronic inflammation by suppressing nuclear factor-κB activity to inhibit cell proliferation and invasion in colorectal cancer.

Authors:  Mingming Zhu; Wen Zhang; Jun Ma; Youguo Dai; Qi Zhang; Qin Liu; Burong Yang; Gang Li
Journal:  Exp Ther Med       Date:  2019-09-20       Impact factor: 2.447

10.  Prognostic Roles of Blood Inflammatory Markers in Hepatocellular Carcinoma Patients Taking Sorafenib. A Systematic Review and Meta-Analysis.

Authors:  Lixing Liu; Yang Gong; Qinglin Zhang; Panpan Cai; Li Feng
Journal:  Front Oncol       Date:  2020-01-29       Impact factor: 6.244
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.